807 related articles for article (PubMed ID: 28238187)
1. Circulating tumor cells: clinical validity and utility.
Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of circulating tumor cells: an update.
Vasseur A; Kiavue N; Bidard FC; Pierga JY; Cabel L
Mol Oncol; 2021 Jun; 15(6):1647-1666. PubMed ID: 33289351
[TBL] [Abstract][Full Text] [Related]
3. Clinical indications for, and the future of, circulating tumor cells.
Moon DH; Lindsay DP; Hong S; Wang AZ
Adv Drug Deliv Rev; 2018 Feb; 125():143-150. PubMed ID: 29626548
[TBL] [Abstract][Full Text] [Related]
4. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
[TBL] [Abstract][Full Text] [Related]
5. Circulating Tumor Cells: Overview and Opportunities in Cytology.
Sundling KE; Lowe AC
Adv Anat Pathol; 2019 Jan; 26(1):56-63. PubMed ID: 30325755
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K
Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129
[TBL] [Abstract][Full Text] [Related]
7. Circulating Tumor Cells in Breast Cancer.
Liang DH; Hall C; Lucci A
Recent Results Cancer Res; 2020; 215():127-145. PubMed ID: 31605227
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells as promising novel biomarkers in solid cancers.
Lianidou ES; Strati A; Markou A
Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
[TBL] [Abstract][Full Text] [Related]
10. Functional Studies on Viable Circulating Tumor Cells.
Pantel K; Alix-Panabières C
Clin Chem; 2016 Feb; 62(2):328-34. PubMed ID: 26637479
[TBL] [Abstract][Full Text] [Related]
11. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.
Khoja L; Lorigan P; Zhou C; Lancashire M; Booth J; Cummings J; Califano R; Clack G; Hughes A; Dive C
J Invest Dermatol; 2013 Jun; 133(6):1582-90. PubMed ID: 23223143
[TBL] [Abstract][Full Text] [Related]
12. The Role of CTCs as Tumor Biomarkers.
Lianidou ES; Markou A; Strati A
Adv Exp Med Biol; 2015; 867():341-67. PubMed ID: 26530376
[TBL] [Abstract][Full Text] [Related]
13. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
[TBL] [Abstract][Full Text] [Related]
14. The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study.
Yang L; Lv Z; Xia W; Zhang W; Xin Y; Yuan H; Chen Y; Hu X; Lv Y; Xu Q; Weng X; Ni C
Clin Transl Oncol; 2018 Jul; 20(7):912-921. PubMed ID: 29243075
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells in solid tumor in metastatic and localized stages.
Maestro LM; Sastre J; Rafael SB; Veganzones SB; Vidaurreta M; Martín M; Olivier C; DE La Orden VB; Garcia-Saenz JA; Alfonso R; Arroyo M; Diaz-Rubio E
Anticancer Res; 2009 Nov; 29(11):4839-43. PubMed ID: 20032444
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and clinical utility of circulating tumor cells in the treatment of prostate cancer.
Lorente D; Mateo J; de Bono JS
Am Soc Clin Oncol Educ Book; 2014; ():e197-203. PubMed ID: 24857103
[TBL] [Abstract][Full Text] [Related]
17. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
Zhou J; Dong F; Cui F; Xu R; Tang X
Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
[TBL] [Abstract][Full Text] [Related]
18. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
Lianidou ES; Markou A
Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
